A Study of RGLS4326 in Patients With Autosomal Dominant Polycystic Kidney Disease

NCT04536688 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

19

Enrollment

INDUSTRY

Sponsor class

Conditions

Polycystic Kidney Disease, Autosomal Dominant

Interventions

DRUG: RGLS4326

Sponsor

Regulus Therapeutics Inc.